Literature DB >> 1806942

Comparative metabolism of cannabidiol in dog, rat and man.

D J Harvey1, E Samara, R Mechoulam.   

Abstract

Urinary metabolites of cannabidiol (CBD) were extracted from human, dog and rat urine, concentrated by chromatography on Sephadex LH-20, and identified by GC/MS. Over 50 metabolites were identified with considerable species variation. CBD was excreted in substantial concentration from human urine, both in the free state and as its glucuronide. In dog, unusual glucoside conjugates of three metabolites (4''- and 5''-hydroxy and 6-oxo-CBD), not excreted in the unconjugated state, were found as the major metabolites at early times after drug administration. Other metabolites in all three species were mainly acids. Side-chain hydroxylated derivatives of CBD-7-oic acid were particularly abundant in human urine but much less so in dog. In the latter species the major oxidized metabolites were the products of beta-oxidation with further hydroxylation at C-6. A related, but undefined pathway, resulted in loss of three carbon atoms from the side-chain of CBD in man with the production of 2''-hydroxy-tris,nor-CBD-7-oic acid. Previous experiments indicate that 3'-hydroxy-metabolites are the precursors of compounds having this side-chain. Metabolism by the epoxide-diol pathway, resulting in dihydro-diol formation from the delta-8-double bond, gave metabolites in both dog and human urine. It was concluded that CBD could be used as a probe of the mechanism of several types of biotransformation, particularly those related to carboxylic acid metabolism, as intermediates of the type not usually seen with endogenous compounds were excreted in substantial concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806942     DOI: 10.1016/0091-3057(91)90358-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

1.  Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Béla Horváth; Sándor Bátkai; Ogyi Park; Galin Tanchian; Rachel Y Gao; Vivek Patel; David A Wink; Lucas Liaudet; György Haskó; Raphael Mechoulam; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-03-11       Impact factor: 7.376

2.  Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

Authors:  Enkui Hao; Partha Mukhopadhyay; Zongxian Cao; Katalin Erdélyi; Eileen Holovac; Lucas Liaudet; Wen-Shin Lee; György Haskó; Raphael Mechoulam; Pál Pacher
Journal:  Mol Med       Date:  2015-01-06       Impact factor: 6.354

3.  Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.

Authors:  Mateus M Bergamaschi; Allan Barnes; Regina H C Queiroz; Yasmin L Hurd; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-03-15       Impact factor: 4.142

4.  Comparing the prevalence of tetrahydrocannabinol (THC) toxicities in dogs before and after legalization of cannabis in Canada.

Authors:  Molly Joffe; Daniel Joffe
Journal:  Can Vet J       Date:  2020-09       Impact factor: 1.008

5.  Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats.

Authors:  Kelly A Deabold; Wayne S Schwark; Lisa Wolf; Joseph J Wakshlag
Journal:  Animals (Basel)       Date:  2019-10-19       Impact factor: 2.752

Review 6.  Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.

Authors:  María S García-Gutiérrez; Francisco Navarrete; Ani Gasparyan; Amaya Austrich-Olivares; Francisco Sala; Jorge Manzanares
Journal:  Biomolecules       Date:  2020-11-19

Review 7.  Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

Authors:  Raymond J M Niesink; Margriet W van Laar
Journal:  Front Psychiatry       Date:  2013-10-16       Impact factor: 4.157

8.  A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans.

Authors:  Gerhard Nahler; Franjo Grotenhermen; Antonio Waldo Zuardi; José A S Crippa
Journal:  Cannabis Cannabinoid Res       Date:  2017-05-01

9.  Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

Authors:  Lauri-Jo Gamble; Jordyn M Boesch; Christopher W Frye; Wayne S Schwark; Sabine Mann; Lisa Wolfe; Holly Brown; Erin S Berthelsen; Joseph J Wakshlag
Journal:  Front Vet Sci       Date:  2018-07-23

10.  Evidence for side effects of cannabidiol (CBD) products and their non-conformity on the European food market - response to the European Industrial Hemp Association.

Authors:  Dirk W Lachenmeier; Stephan G Walch
Journal:  F1000Res       Date:  2020-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.